PUBLISHER: The Business Research Company | PRODUCT CODE: 1945281
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945281
Hemodialysis chairs are specialized pieces of medical furniture crafted to offer comfort and support to individuals undergoing hemodialysis treatment. Hemodialysis is a medical process employed to eliminate waste products and excess fluids from the blood when the kidneys are incapable of performing this function adequately. The significance of hemodialysis chairs lies in their pivotal role in ensuring that patients can engage in activities, maintain mobility, and have easy accessibility.
The primary classifications of hemodialysis chairs encompass manual hemodialysis chairs and electrical hemodialysis chairs. A manual hemodialysis chair is a specially designed medical chair tailored for use in hemodialysis procedures. These chairs are constructed using various materials, including leather, vinyl, and others. They find application across diverse end-users such as hospitals, hemodialysis research centers, government organizations, ambulatory centers, and home care.
Tariffs are impacting the hemodialysis chairs market by increasing costs of imported steel frames, electric actuators, motors, upholstery materials, and electronic control components used in manual and electric dialysis chairs. Hospitals and dialysis centers in North America and Europe are most affected due to reliance on imported medical furniture components, while Asia-Pacific faces cost pressure on export-oriented production. These tariffs are raising procurement costs and slowing facility upgrades. However, they are also encouraging local manufacturing, regional sourcing of components, and innovation in cost-efficient and modular dialysis chair designs.
The hemodialysis chairs market research report is one of a series of new reports from The Business Research Company that provides hemodialysis chairs market statistics, including hemodialysis chairs industry global market size, regional shares, competitors with a hemodialysis chairs market share, detailed hemodialysis chairs market segments, market trends and opportunities, and any further data you may need to thrive in the hemodialysis chairs industry. This hemodialysis chairs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemodialysis chairs market size has grown steadily in recent years. It will grow from $90.7 billion in 2025 to $95 billion in 2026 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to increasing prevalence of chronic kidney disease, expansion of dialysis treatment centers, growing demand for patient-centric care environments, rising healthcare infrastructure investments, availability of durable medical furniture.
The hemodialysis chairs market size is expected to see steady growth in the next few years. It will grow to $114.04 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to increasing adoption of home-based dialysis care, rising focus on patient comfort and mobility, expansion of outpatient dialysis centers, growing demand for smart and adjustable medical furniture, increasing investments in renal care infrastructure. Major trends in the forecast period include increasing adoption of electrically adjustable dialysis chairs, rising demand for enhanced patient comfort solutions, growing integration of ergonomic and safety features, expansion of home dialysis furniture solutions, enhanced focus on long-duration treatment support.
The increasing number of diabetes cases is expected to drive the growth of the hemodialysis chairs market in the coming years. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels. The growing prevalence of obesity, largely caused by high-calorie and highly processed diets, is a major factor contributing to the rise in diabetes, as excess body weight increases insulin resistance. This trend has led to higher demand for hemodialysis chairs, as individuals with diabetes often require hemodialysis treatment to manage complications associated with the condition, thereby increasing the need for specialized equipment such as hemodialysis chairs. For instance, in April 2025, according to the International Diabetes Federation, a Belgium-based global alliance of more than 250 national diabetes associations, over 9.5 million people were living with type 1 diabetes in 2024, including 1.9 million children and adolescents under the age of 20. By 2050, the global diabetes population is projected to reach 853 million. Therefore, the growing incidence of diabetes is driving the expansion of the hemodialysis chairs market.
Major companies operating in the hemodialysis chairs market are increasingly emphasizing technological advancements, such as ergonomically designed and electrically adjustable therapy chairs for home haemodialysis, to enhance patient comfort, safety, and workflow efficiency. Ergonomically optimized, electrically adjustable therapy chairs for home haemodialysis incorporate motorized positioning controls, user-friendly handsets, rapid emergency or Trendelenburg positioning, and dialysis-specific upholstery and structural design to support stable vascular access, minimize caregiver strain, and ensure comfort during frequent short-duration treatments. For instance, in June 2024, Digiterm Ltd., a Hungary-based manufacturer of visual information systems and medical equipment, launched the Comfort-1 Eco therapy chair. The chair enables simultaneous electric adjustment of the backrest and legrest via an intuitive remote controller and features fast Trendelenburg positioning, allowing patients to quickly achieve comfortable or emergency positions during home haemodialysis sessions. Its optional transport configuration and dialysis-oriented design facilitate easy patient movement within facilities while maintaining ergonomic working conditions and procedural safety. In addition, its easy-to-clean, customizable upholstery and compact, cost-efficient construction are designed to support broader adoption of dedicated haemodialysis seating solutions across both home-based and in-center care settings.
In June 2023, AngioDynamics Inc., a US-based medical device company, acquired Merit Medical Systems Inc. for $132.5 million. This acquisition aims to bolster AngioDynamics' position in the dialysis and biopsy market, expanding its range of specialist dialysis devices, including the surfacer system, HeRO graft, and Wrapsody cell-impermeable endoprosthesis. Merit Medical Systems Inc., a US-based company specializing in manufacturing hemodialysis chairs, becomes part of this effort to reinforce AngioDynamics' presence in the market.
Major companies operating in the hemodialysis chairs market are Fresenius Medical Care AG & Co KGaA, Baxter International Inc, B Braun Melsungen AG, Nipro Corporation, Champion Manufacturing Inc, Digiterm Ltd, Guangdong Dongpin Beauty & Medical Technology Co Ltd, Likamed GmbH, Acime-Frame (Acime), IBIOM Instruments Ltee, Diasol Inc, SEERS Medical Limited, Toray Medical Co Ltd, JMS Co Ltd, Quanta Dialysis (Italy), Nanjing KangQiao Medical Equipment Co Ltd, Jiangsu Fengyuan Medical Equipment Co Ltd, Dongpin Beauty & Medical Co Ltd (China), Indtech Healthcare Pvt Ltd, Meditek Engineers Pvt Ltd
Asia Pacific was the largest region in the hemodialysis chairs market in 2025. The regions covered in the hemodialysis chairs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hemodialysis chairs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hemodialysis chair market consists of sales of power-assisted hemodialysis chairs, and customizable hemodialysis chairs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hemodialysis Chairs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hemodialysis chairs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hemodialysis chairs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemodialysis chairs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.